Abstract Background Treatment with the sodium‐glucose co‐transporter 2 (SGLT2) inhibitor canagliflozin in insulin dysregulated (ID) horses has shown promising results in randomised clinical trials. Larger field studies are needed to further evaluate treatment responses and potential adverse effects under real‐world conditions.
Moa Hällbom +3 more
wiley +1 more source
Decisions about palliative care and social determinants of health in intensive care units: a scoping review. [PDF]
Yun H, Kim JY, Han E, Jang Y.
europepmc +1 more source
Does Antibiotic Treatment Before Bone Biopsy Affects the Identification of Bacterial Pathogens From Bone Culture in Diabetic Foot Osteomyelitis? A Systematic Review and Meta Analysis. [PDF]
Lavery LA +6 more
europepmc +1 more source
Hidden barriers and ground reality in implementing Supreme Court of India directives to withdraw/withhold life-sustaining medical treatment. [PDF]
Havaldar AA.
europepmc +1 more source
Idiopathic Midaortic Syndrome: An Unusual Case of Acute Kidney Injury (AKI) in Secondary Hypertension With Renal Collaterals in an Adult. [PDF]
Kamble R +4 more
europepmc +1 more source
The Role of Inflammatory Biomarkers and Microbiological Profile in Clinical Decision-Making for Antibiotic Therapy in Pediatric Patients: A Retrospective Study. [PDF]
Alidema FB +2 more
europepmc +1 more source

